È necessario avere un abbonamento a JoVE per visualizzare questo. Accedi o inizia la tua prova gratuita.
1Centre for Translational Omics, Genetics and Genomic Medicine Deptartment, Great Ormond Street Institute of Child Health,University College London, 2Dementia Research Centre, Institute of Neurology,University College London, 3Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy,University of Gothenburg, 4Neurology Unit, Department of Pathophysiology and Transplantation,University of Milan, 5Great Ormond Street Hospital for Children,University College London
Capitoli
- 00:05Titolo
- 01:05Preparation of Standard Peptides
- 03:33LC-MRM Method Development and Data Analysis
- 05:12Results: High-throughput, Multiplex CSF Assay for Quantification of Neurodegeneration Markers and Detection of ApoE Isoforms
- 06:17Conclusion
Vi beskriver en high-throughput, multiplex, og målrettet proteomik cerebrospinalvæske (CSF) assay udviklet med potentiale for klinisk oversættelse. Testen kan kvantificere potentielle markører og risikofaktorer for neurodegeneration, såsom apolipoprotein E-varianter (E2, E3 og E4), og måle deres allel udtryk.
